Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
OPDUALAG Inf Konz Durchstf 20 ml
Drug
Opdualag, Konzentrat zur Herstellung einer Infusionslösung
fortgeschrittenes Melanom
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
12/23/2022
12/22/2027
Dosage strength
Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml), Konzentrat zur Herstellung einer Infusionslösung
fortgeschrittenes Melanom
01
Z – approved
Package
7680686090019
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
80 mg relatlimabum
240 mg nivolumabum
240 mg nivolumabum
histidinum
histidini hydrochloridum monohydricum
saccharum
polysorbatum 80
acidum penteticum
aqua ad iniectabile
histidini hydrochloridum monohydricum
saccharum
polysorbatum 80
acidum penteticum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
6907.50
None
Yes
10%
No
Authorisation holder
7601001010703
Bristol-Myers Squibb SA
Hinterbergstrasse 16
6312 Steinhausen (ZG)
Hinterbergstrasse 16
6312 Steinhausen (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.